<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Wellness Vision — Price changes</title>
    <link>https://wellnessvision.health/price-changes/</link>
    <atom:link href="https://wellnessvision.health/price-changes/rss.xml" rel="self" type="application/rss+xml"/>
    <description>New co-payments, subsidies and drug prices — each with an official source and date.</description>
    <language>en</language>
    <item>
      <title>From January 1, 2027: Germany: fixed dental subsidy falls to 50/60/65%</title>
      <link>https://wellnessvision.health/price-changes/#festzuschuss-zahnersatz-2027</link>
      <guid isPermaLink="false">wv-en-festzuschuss-zahnersatz-2027</guid>
      <pubDate>Mon, 26 Oct 2026 08:00:00 GMT</pubDate>
      <description>For treatment plans approved from January 1, 2027, statutory insurance pays 50% of the standard-care amount, 60% or 65% with a five- or ten-year check-up record — down from 60/70/75%. Plans approved earlier keep the old rates; hardship cases still get the full standard-care amount.</description>
    </item>
    <item>
      <title>From January 1, 2027: Medicare negotiated price for semaglutide takes effect</title>
      <link>https://wellnessvision.health/price-changes/#medicare-mfp-semaglutid-2027</link>
      <guid isPermaLink="false">wv-en-medicare-mfp-semaglutid-2027</guid>
      <pubDate>Mon, 26 Oct 2026 08:00:00 GMT</pubDate>
      <description>From January 1, 2027, Medicare's negotiated price for semaglutide (Ozempic, Rybelsus, Wegovy) applies: $274 for a 30-day supply, 71% below the 2024 list price; $385.63 for a Wegovy pack of four 2.4 mg pens.</description>
    </item>
    <item>
      <title>From January 1, 2027: US list price of Ozempic and Wegovy falls to $675</title>
      <link>https://wellnessvision.health/price-changes/#novo-listenpreis-675-2027</link>
      <guid isPermaLink="false">wv-en-novo-listenpreis-675-2027</guid>
      <pubDate>Mon, 26 Oct 2026 08:00:00 GMT</pubDate>
      <description>Novo Nordisk announced that the US list price of Ozempic, Wegovy and Rybelsus falls to $675 a month for all doses from January 1, 2027 — about 35% lower for Ozempic.</description>
    </item>
    <item>
      <title>From January 1, 2027: Germany: prescription co-payment rises to €7.50–€15</title>
      <link>https://wellnessvision.health/price-changes/#zuzahlung-arzneimittel-2027</link>
      <guid isPermaLink="false">wv-en-zuzahlung-arzneimittel-2027</guid>
      <pubDate>Mon, 26 Oct 2026 08:00:00 GMT</pubDate>
      <description>From January 1, 2027, people with statutory insurance in Germany pay 10% of the price per pack, at least €7.50 and at most €15 — up from €5–€10; never more than the price itself.</description>
    </item>
    <item>
      <title>From January 1, 2027: Germany: hospital co-payment rises to €15 a day</title>
      <link>https://wellnessvision.health/price-changes/#zuzahlung-krankenhaus-2027</link>
      <guid isPermaLink="false">wv-en-zuzahlung-krankenhaus-2027</guid>
      <pubDate>Mon, 26 Oct 2026 08:00:00 GMT</pubDate>
      <description>From January 1, 2027, the co-payment for an inpatient hospital stay is €15 per calendar day instead of €10, still for at most 28 days a year — up to €420 instead of €280.</description>
    </item>
    <item>
      <title>From July 1, 2026: Medicare: $50 copay for weight-loss GLP-1s (temporary)</title>
      <link>https://wellnessvision.health/price-changes/#medicare-glp1-bridge-2026</link>
      <guid isPermaLink="false">wv-en-medicare-glp1-bridge-2026</guid>
      <pubDate>Mon, 26 Oct 2026 08:00:00 GMT</pubDate>
      <description>Since July 1, 2026, Medicare enrollees pay a $50 copay for certain weight-loss GLP-1 drugs (Wegovy, Zepbound KwikPen, Foundayo) — a temporary program running through December 31, 2027.</description>
    </item>
  </channel>
</rss>
